03/06/2021 12:44 (UTC)
Bangalore, June 3 (EFE).- India came closer to getting its second indigenous Covid-19 vaccine after the government inked a deal with a pharma company for 300 million doses to be available in the coming months, the health ministry reported Thursday. The country facing acute vaccine shortages is using a home-grown Covaxin developed by Bharat Biotech laboratory. Covaxin is used in India's vaccination drive with British-Swedish firm AstraZeneca's Covishield and the Russian Sputnik V. (Camera: JAGADEESH NV). SHOT LIST: MEMBERS OF LGBTQI+ COMMUNITY RECEIVE FOOD KIT DURING LOCKDOWN IN BANGALORE, INDIA AND STUDENTS QUEUE TO RECEIVE A VACCINE DURING A VACCINATION DRIVE IN BANGALORE, INDIA.
Product Suggestions